NEWS

Efforts to Combat E-Cigarette Misuse Could Backfire

Efforts to Combat E-Cigarette Misuse Could Backfire

Recent news about e-cigarette misuse has fueled both public misperception and policy responses that are likely to have unintended consequences. As the US vaping market continues to evolve, policymakers face the tricky challenge of safeguarding the potential for positive public health outcomes from e-cigarettes, which offer a lower-risk alternative to traditional cigarettes, while ensuring reasonable protections against youth use.

read more
MGA’s Alex Brill on Liberty & Justice for All

MGA’s Alex Brill on Liberty & Justice for All

“I advocate and support a carbon tax, but not just blindly, not just any carbon tax. It is critically important that the carbon tax be revenue neutral. That at the time at which this policy is put in place its done in a matter in which the revenues expected to be generated from the carbon tax are used to reduce other taxes that are more distortionary. This is what we would call the principles of basic tax reform.”

read more
New Belgium Brewery’s employees think like owners. Because they are.

New Belgium Brewery’s employees think like owners. Because they are.

Alex Brill was quoted in Fast Company for his research on tax policy effects on business:

“… [Brill] has found that employees in ESOPs “get better at the job, and instead of quitting as soon as they get skills, they stay and get more skills.” Companies with ESOPs require fewer managers, as AEI’s Brill discovered in his research, because workers are given more freedom and are better able to manage themselves.”

read more
Rising Tax Burdens for Those Earning the Most

Rising Tax Burdens for Those Earning the Most

Is the tax code sufficiently progressive? The answer depends not only on the values of the person answering the question, but it also is a surprisingly tricky empirical exercise. What counts as income and who pays the corporate tax? How should one measure households?

read more
Hey World: Do Not Ban E-Cigarettes

Hey World: Do Not Ban E-Cigarettes

There is a hot debate in many countries over youth use of e-cigarettes, electronic devices that deliver nicotine to consumers without the deadly tar found in the smoke from traditional cigarettes. Although nicotine is not a carcinogen, it is still bad for developing brains and should not be used by young adults or pregnant women. At the same time, e-cigarettes offer real advantages over traditional tobacco products for smokers who are otherwise unable to quit.

read more
The Economics of Biologic Drugs

The Economics of Biologic Drugs

The market for biologic drugs in the United States is large and growing. Total US biologic sales in 2018 is estimated to have been $125 billion, an increase of 50 percent since 2014.

read more
Debate Over Whether Biologics Constitute Natural Monopolies Continues

Debate Over Whether Biologics Constitute Natural Monopolies Continues

“Peter B. Bach, MD, a well-known critic of high drug prices, along with Jennifer A. Ohn, MPH, Preston Atteberry, MD, and Mark Trusheim, MSc, first wrote in April that biosimilar competition is an economically inefficient way to achieve the goal of lower prices; the biosimilar environment is different than the one that exists in the generic marketplace for small-molecule drugs. These authors said, instead, that biosimilars are natural monopolies and as such need price regulation in order for them to succeed and for prices to come down.”

read more
MGA’s Alex Brill on CNBC’s Squawk Box

MGA’s Alex Brill on CNBC’s Squawk Box

“I think its a solid [GDP] number. Obviously the inventory piece creates a little bit of volatility and the investment numbers are a disappointment, but not a surprise. Overall we see a strong consumers. On the Fed, I would agree with Austin. What the Fed has to do now more than ever is try to block out the political noise, focus on the data and make the best call to boost their credibility or sustain their credibility.”

read more

Have a Question?

Get In Touch

Get Our latest news

subscribe

Address

1350 Connecticut Avenue NW
Suite 610
Washington, DC 20036

Follow Us